adplus-dvertising
Connect with us

Economy

Producing vaccines, creating good jobs, and building an economy that works for all Canadians – Prime Minister of Canada

Published

 on

Amid global economic uncertainty, the Government of Canada will continue to be there for people – just like we were throughout the pandemic. By continuing to attract investment in research and development and manufacturing, we will continue to create good, middle class jobs and build an economy that works for all Canadians.

The Prime Minister, Justin Trudeau, took part in the ground-breaking of vaccine developer Moderna’s new state-of-the-art mRNA vaccine manufacturing facility in Laval, Quebec. When completed, this new facility will be able to produce up to 100 million made-in-Canada mRNA vaccine doses annually and will create hundreds of good jobs. The Prime Minister also took the opportunity to remind Canadians to keep up to date with their COVID-19 vaccinations, including getting booster shots when eligible to protect themselves and their loved ones.

The facility is expected to be completed in 2024 at the earliest. In addition to COVID-19 vaccines, it is expected to be able to produce vaccines for other respiratory diseases, such as influenza – pending their ongoing development by Moderna and approval by Health Canada.

During the pandemic, we worked hard to secure life-saving personal protective equipment, invest in our health care system, and ensure everyone eligible in Canada could get vaccinated. As we move forward, we will strengthen our biomanufacturing and life sciences sector to re-establish Canada’s domestic vaccine manufacturing capability, bring Canadian innovation to the front lines of tomorrow’s health solutions, and ensure we are better prepared for future health crises – all while growing the economy and creating good jobs.

Quotes

“COVID-19 vaccines saved lives and got Canadians back to doing the things they love. Breaking ground on this vaccine manufacturing facility is an important milestone toward ensuring that Canadian workers and Canadian innovation play a key role in keeping our communities safe building an economy that works for all Canadians.”

The Rt. Hon. Justin Trudeau, Prime Minister of Canada

“Today’s ground-breaking for Moderna’s facility in Laval brings us one step closer to seeing the future of vaccines being developed right here in Canada. With talented workers, researchers and students, Laval will play a key role in global health and health innovation. Moderna’s presence in Canada will strengthen our national biomanufacturing ecosystem, positioning the entire sector to continue to grow and to create even more jobs right across the country.”

The Hon. François-Philippe Champagne, Minister of Innovation, Science and Industry

“Staying up to date with vaccination continues to be one of the most effective ways to protect ourselves against serious illness, hospitalization, and death from COVID-19. By bolstering Canada’s domestic manufacturing capacity, we are strengthening domestic health security and pandemic preparedness through timely access to innovative, cutting-edge vaccines that help us save lives.”

The Hon. Jean-Yves Duclos, Minister of Health

“Our government is continuing to ensure Canadians have access to the latest vaccines now and into the future. Breaking ground on this new facility is another important step in our partnership with Moderna to build a domestic biomanufacturing capacity for mRNA vaccines. Access to made-in-Canada vaccines will help ensure we are ready in the event of a future pandemic. We have, and will always work to protect the health and safety of everyone in Canada.”

The Hon. Helena Jaczek, Minister of Public Services and Procurement

“I am very pleased that we were able to attract Moderna to Laval. Its arrival strengthens Laval’s long-established biopharmaceutical sector and kicks off Phase II of Biotech City.”

Stéphane Boyer, Mayor of Laval

“Today marks another milestone for Moderna and our long-term strategic partnership with the Government of Canada to support pandemic preparedness. We are moving quickly to ensure local supply and manufacturing capabilities of mRNA vaccines for Canadians, with the goal of completing our manufacturing facility in Quebec by the end of 2024.”

Noubar Afeyan, Co-founder and Chairman, Moderna

Quick Facts

  • Moderna is a pioneering biotechnology company specializing in mRNA therapeutics and vaccines. In August 2021, the Government of Canada announced a memorandum of understanding with Moderna to build a state-of-the-art mRNA vaccine production facility in Canada. In April 2022, the Prime Minister announced that plans were moving forward toward building this new facility in Quebec. Since then, a definitive agreement has been finalized between the Government of Canada and Moderna.
  • Moderna is partnering with Canada’s leading research universities and institutions to help advance cutting-edge research and development here at home.
  • Through the Strategic Innovation Fund, the government has supported projects from coast to coast to coast. This includes up to $415 million to support Sanofi in building an end-to-end influenza vaccine manufacturing facility in Toronto, Ontario; up to $175.6 million for AbCellera toward its antibody therapy research and the construction of an antibody production facility in British Columbia; $39.8 million for BioVectra to build a state-of-the-art facility in Prince Edward Island and reconfigure their facilities in Nova Scotia.
  • The government has also invested $126 million to build a new Biologics Manufacturing Centre at the National Research Council Canada’s Royalmount site in Montréal. The facility received its drug establishment licence in August 2022 and will be capable of large-quantity, end-to-end production of vaccines ‒ approximately 24 million doses annually.
  • Budget 2021 provided a total of $2.2 billion over seven years toward growing a vibrant domestic life sciences sector and securing pandemic preparedness. This funding will help build Canada’s talent pipeline and research systems, as well as foster the growth of Canadian life sciences firms.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite up more than 250 points, U.S. stock markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 250 points in late-morning trading, led by strength in the base metal and technology sectors, while U.S. stock markets also charged higher.

The S&P/TSX composite index was up 254.62 points at 23,847.22.

In New York, the Dow Jones industrial average was up 432.77 points at 41,935.87. The S&P 500 index was up 96.38 points at 5,714.64, while the Nasdaq composite was up 486.12 points at 18,059.42.

The Canadian dollar traded for 73.68 cents US compared with 73.58 cents US on Thursday.

The November crude oil contract was up 89 cents at US$70.77 per barrel and the October natural gas contract was down a penny at US2.27 per mmBTU.

The December gold contract was up US$9.40 at US$2,608.00 an ounce and the December copper contract was up four cents at US$4.33 a pound.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

Construction wraps on indoor supervised site for people who inhale drugs in Vancouver

Published

 on

 

VANCOUVER – Supervised injection sites are saving the lives of drug users everyday, but the same support is not being offered to people who inhale illicit drugs, the head of the BC Centre for Excellence in HIV/AIDS says.

Dr. Julio Montaner said the construction of Vancouver’s first indoor supervised site for people who inhale drugs comes as the percentage of people who die from smoking drugs continues to climb.

The location in the Downtown Eastside at the Hope to Health Research and Innovation Centre was unveiled Wednesday after construction was complete, and Montaner said people could start using the specialized rooms in a matter of weeks after final approvals from the city and federal government.

“If we don’t create mechanisms for these individuals to be able to use safely and engage with the medical system, and generate points of entry into the medical system, we will never be able to solve the problem,” he said.

“Now, I’m not here to tell you that we will fix it tomorrow, but denying it or ignoring it, or throw it under the bus, or under the carpet is no way to fix it, so we need to take proactive action.”

Nearly two-thirds of overdose deaths in British Columbia in 2023 came after smoking illicit drugs, yet only 40 per cent of supervised consumption sites in the province offer a safe place to smoke, often outdoors, in a tent.

The centre has been running a supervised injection site for years which sees more than a thousand people monthly and last month resuscitated five people who were overdosing.

The new facilities offer indoor, individual, negative-pressure rooms that allow fresh air to circulate and can clear out smoke in 30 to 60 seconds while users are monitored by trained nurses.

Advocates calling for more supervised inhalation sites have previously said the rules for setting up sites are overly complicated at a time when the province is facing an overdose crisis.

More than 15,000 people have died of overdoses since the public health emergency was declared in B.C. in April 2016.

Kate Salters, a senior researcher at the centre, said they worked with mechanical and chemical engineers to make sure the site is up to code and abidies by the highest standard of occupational health and safety.

“This is just another tool in our tool box to make sure that we’re offering life-saving services to those who are using drugs,” she said.

Montaner acknowledged the process to get the site up and running took “an inordinate amount of time,” but said the centre worked hard to follow all regulations.

“We feel that doing this right, with appropriate scientific background, in a medically supervised environment, etc, etc, allows us to derive the data that ultimately will be sufficiently convincing for not just our leaders, but also the leaders across the country and across the world, to embrace the strategies that we are trying to develop.” he said.

Montaner said building the facility was possible thanks to a single $4-million donation from a longtime supporter.

Construction finished with less than a week before the launch of the next provincial election campaign and within a year of the next federal election.

Montaner said he is concerned about “some of the things that have been said publicly by some of the political leaders in the province and in the country.”

“We want to bring awareness to the people that this is a serious undertaking. This is a very massive investment, and we need to protect it for the benefit of people who are unfortunately drug dependent.” he said.

This report by The Canadian Press was first published Sept. 18, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending